Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Actinium Pharmaceuticals, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 984K | Dec 28, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATNM | Actinium Pharmaceuticals, Inc. | Dec 28, 2023 | 1 | $0 | 4 | Dec 29, 2023 | Chief Executive Officer, Director |
ATNM | Actinium Pharmaceuticals, Inc. | Aug 17, 2022 | 1 | $0 | 4 | Aug 19, 2022 | Chief Executive Officer, Director |
ATNM | Actinium Pharmaceuticals, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Chief Executive Officer, Director |
ATNM | Actinium Pharmaceuticals, Inc. | Sep 1, 2021 | 1 | $0 | 4 | Sep 3, 2021 | Chief Executive Officer, Director |